Benzene

Benzene

SCHEMBL11242418

CCC(=O)C(C)C(=O)O.c1ccccc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.38
TP53 P04637 1/20 0.36
SLC7A5 Q01650 1/20 0.36
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 1/20 0.35
HTR2A P28223 2/20 0.35
HRH1 P35367 2/20 0.35
CHRM1 P11229 1/20 0.35
AKR1A1 P14550 1/20 0.35
CHRM3 P20309 1/20 0.35
HTR2C P28335 1/20 0.35
ADRA1A P35348 1/20 0.35
DRD3 P35462 1/20 0.35
SLC6A3 Q01959 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9315437 0.95
SCHEMBL166454 0.95
Toluene SCHEMBL6905809 0.85 TSHR (0.42) ALDH1A1CYP1A2HTR2AHRH1CES2
SCHEMBL31174525 0.83 ALDH1A1 (0.37) FFAR3TP53SLC7A5ALDH1A1HTR2A
SCHEMBL2546877 0.80 ALDH1A1 (0.41) FFAR3ALDH1A1TDP1TSHR
SCHEMBL10412722 0.77 ACE2 (0.47) MAPT
Methylmalonic Acid SCHEMBL27861389 0.76 TP53 (0.50) TP53SLC7A5MAPTTSHR
SCHEMBL16612661 0.75 TDP1 (0.41) FFAR3TP53SLC7A5ALDH1A1CYP1A2
SCHEMBL28279631 0.75 TDP1 (0.37) FFAR3ALDH1A1TDP1TSHR
Methylmalonic Acid SCHEMBL995094 0.75 FFAR3 (0.62) FFAR3TP53SLC7A5ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4321368-A X-RAY CONTRAST MEDIA MALLINCKRODT, INC. (US) 1982-03-23 US disclosed
EP-0009362-A1 Heterocyclic derivatives of guanidine, their preparation and pharmaceutical formulations comprising them McNeilab, Inc. (US) 1980-04-02 EP disclosed